Literature DB >> 24714803

De novo cerebral arteriovenous malformations: is epileptic seizure a potential trigger?

Jun Wu1, Yu Li, Yong Cao, Shuo Wang.   

Abstract

MATERIAL AND METHODS: The pathogenesis of cerebral arteriovenous malformations (cAVMs) is still not well understood. Generally, cAVMs are thought to be congenital lesions originating prenatally. We report a 7-year-old boy diagnosed with a de novo cAVM after 3 years of recurrent epileptic seizures.
RESULTS: MR imaging at 4 years of age was normal. Follow-up MR imaging 3 years later demonstrated a de novo 2-cm cAVM in the right occipital lobe, confirmed by conventional angiography. We reviewed five previously reported cases of de novo cAVMs who did not have a previous neurovascular abnormality. Including our case, recurrent epileptic seizures are the major presentation (83.3 %) before de novo cAVM occurrence.
CONCLUSION: We suggest that epileptic seizure is a potential trigger of de novo cAVMs.

Entities:  

Mesh:

Year:  2014        PMID: 24714803     DOI: 10.1007/s00381-014-2413-8

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  29 in total

Review 1.  Spontaneous thrombosis of a residual arteriovenous malformation in eloquent cortex after surgery: case report.

Authors:  Bernard R Bendok; Christopher C Getch; Mir Jafer Ali; Todd Parish; H Hunt Batjer
Journal:  Neurosurgery       Date:  2002-05       Impact factor: 4.654

Review 2.  De novo cerebral arteriovenous malformation: case report and literature review.

Authors:  J Stevens; J L Leach; T Abruzzo; B V Jones
Journal:  AJNR Am J Neuroradiol       Date:  2008-09-03       Impact factor: 3.825

3.  Brain arteriovenous malformation pathogenesis: a response-to-injury paradigm.

Authors:  Helen Kim; Hua Su; Shantel Weinsheimer; Ludmila Pawlikowska; William L Young
Journal:  Acta Neurochir Suppl       Date:  2011

4.  De novo presentation of an arteriovenous malformation. Case report and review of the literature.

Authors:  L Fernando Gonzalez; Ruth E Bristol; Randall W Porter; Robert F Spetzler
Journal:  J Neurosurg       Date:  2005-04       Impact factor: 5.115

5.  De novo arteriovenous malformations: case report and review of the literature.

Authors:  Amit Mahajan; Tejas C Manchandia; Grahame Gould; Ketan R Bulsara
Journal:  Neurosurg Rev       Date:  2009-09-29       Impact factor: 3.042

6.  Marked growth of an angiographically occult arteriovenous malformation: case report.

Authors:  T Morioka; S Nishio; T Hikita; L H Chung; T Soejima
Journal:  Neurosurgery       Date:  1988-07       Impact factor: 4.654

7.  Symptomatic de novo arteriovenous malformation appearing 17 years after the resection of two other arteriovenous malformations in childhood: case report.

Authors:  Hideaki Akimoto; Kiyohide Komatsu; Yoshihiro Kubota
Journal:  Neurosurgery       Date:  2003-01       Impact factor: 4.654

8.  Gene microarray analysis of human brain arteriovenous malformations.

Authors:  Tomoki Hashimoto; Michael T Lawton; Gen Wen; Guo-Yuan Yang; Thomas Chaly; Campbell L Stewart; Holly K Dressman; Nicholas M Barbaro; Douglas A Marchuk; William L Young
Journal:  Neurosurgery       Date:  2004-02       Impact factor: 4.654

9.  De novo multiple dural arteriovenous fistulas and arteriovenous malformation after embolization of cerebral arteriovenous fistula: case report.

Authors:  Yahui Bai; Chuan He; Hongqi Zhang; Feng Ling
Journal:  Childs Nerv Syst       Date:  2012-09-01       Impact factor: 1.475

10.  Endothelial Notch signaling is upregulated in human brain arteriovenous malformations and a mouse model of the disease.

Authors:  Patrick A Murphy; Gloria Lu; Steven Shiah; Andrew W Bollen; Rong A Wang
Journal:  Lab Invest       Date:  2009-06-22       Impact factor: 5.662

View more
  1 in total

Review 1.  'De Novo' Brain AVMs-Hypotheses for Development and a Systematic Review of Reported Cases.

Authors:  Ioan Alexandru Florian; Lehel Beni; Vlad Moisoiu; Teodora Larisa Timis; Ioan Stefan Florian; Adrian Balașa; Ioana Berindan-Neagoe
Journal:  Medicina (Kaunas)       Date:  2021-02-26       Impact factor: 2.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.